TP53 and cancer: Its involvement also extends to critical signaling pathways, including MELK (Xie and Hu, 2020), MAP2K4 (Wang B. et al., 2022), and p53 (Zhang X. et al., 2019) signaling pathways, underscoring its intricate role in cancers.